Latest Listings And Ipos News

Perpetual Resources has identified a new lithium-bearing pegmatite trend exceeding 400 metres at its Mauricio Target in Brazil’s Lithium Valley, reinforcing the potential for multiple mineralised bodies within its Igrejinha Project. The company is intensifying exploration activities ahead of planned drilling in 2026.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.

Stealth Group Holdings has explained the late filing of a director’s interest notice as an administrative oversight, assuring no market harm occurred. The company has since strengthened its compliance controls to prevent future lapses.

Askari Metals Limited’s AS2OC securities have been suspended from trading pending compliance with ASX Listing Rule 2.5, raising questions about the company’s regulatory standing.

Group One Capital Limited has adopted a comprehensive replacement Constitution at its 2025 Annual General Meeting, setting a refreshed governance framework aligned with current regulatory standards.

NexGen Energy has entered the final phase of federal regulatory approval for its flagship Rook I uranium project, marking a pivotal step toward construction and production. This follows over a decade of environmental assessments and provincial approvals.

Sun Silver Limited’s latest drilling results at the Maverick Springs Project in Nevada confirm thick, consistent silver-gold mineralisation, reinforcing its status as a world-class precious metals system.

The Supreme Court of Western Australia has approved Brightstar Resources’ acquisition of Aurumin Limited, setting the stage for Aurumin’s shares to be suspended and delisted from the ASX by early December.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.